Cognoptix President News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cognoptix president. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cognoptix President Today - Breaking & Trending Today

Cognoptix CEO Dr. Susanne Wilke to Present at the 13th Annual BIOTECH SHOWCASE™ DIGITAL Event

Share this article
Share this article
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer s disease (AD), announces that the company will present at the 13
th Annual Biotech Showcase™ Digital Event, January 11-15, 2021. Dr. Susanne Wilke, Cognoptix President and CEO, will present an overview of the Cognoptix Sapphire II technology in a talk titled Sapphire II: A Breakthrough Technology For The Early-Stage Detection of Alzheimer s Disease.
Dr. Wilke will discuss Cognoptix Sapphire II technology for early AD detection in the lens of the eye. β-amyloid (Aβ) is expressed in the brain where these neurotoxic peptides aggregate into amyloid plaque. Amyloid plaque is established by National Institute of Aging–Alzheimer Association (NIA-AA) criteria to be the earliest and mandatory hallmark pathology for AD. Extensive research has established that AD ....

Justine Lavoye , Susanne Wilke , Marketing Communications , Alzheimer Association , A Breakthrough Technology , Cognoptix Inc , Annual Biotech Showcase , Digital Event , Cognoptix President , Cognoptix Sapphire , National Institute , Mild Cognitive Impairment , ஸூஸந் வில்கே , சந்தைப்படுத்தல் தகவல்தொடர்புகள் , முதுமறதி சங்கம் , ஆண்டு பயோடெக் காட்சி பெட்டி , டிஜிட்டல் நிகழ்வு , தேசிய நிறுவனம் , லேசான அறிவாற்றல் குறைபாடு ,

Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team

Published: Jan 04, 2021

MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix s Chief Financial Officer (CFO).
Dr. Sadowsky is nationally renowned physician and researcher in AD and neurodegenerative diseases. He is a Clinical Professor of Neurology at Nova SE University and was the Founding Director of Research at the Palm Beach Neurology and Premiere Research Institute in West Palm Beach, Florida, a nationally recognized clinical research group focused on AD. Among his notable successes, Dr. Sadowsky has conducted over 300 Alzheimer s clinical trials, including the amyloid PET Amyvid trial and the IDEAS trial. He served on the scientific review board for Alzheimer s Drug Discovery Fo ....

Nova University , United States , New Hampshire , Palm Beach , West Palm Beach , Justine Lavoye , Carlh Sadowsky , Susanne Wilke , Mike Kaswan , Mcintire School Of Commerce , United States Air Force Major , Harvard Business School , Master Of Business Administration , Research Institute , Marketing Communications , Hitchcock Medical Center , University Of Virginia , American Academy Of Neurology , Cornell University Weill Medical College , Cognoptix Inc , Chief Medical Officer , Chief Financial Officer , Clinical Professor , Founding Director , Palm Beach Neurology , Premiere Research Institute ,